Kiora Pharmaceuticals, Inc.
Q1 2022 13F Holders
Symbol
KPRX
CUSIP
49721T101
Type
Equity
Class
COMMON STOCK
Num filings
17
Total reported value, excl. options
$517 k
Compare 2022 Q1 to
2022 Q2
2021 Q4
Manager
Report Date
Value ($000)
Shares
Option Type